ArticleJournal of family medicine and primary care2025
Assessment of the acute encephalitis surveillance system in Bongaigaon district of Assam, India, 2020.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Japanese encephalitis (JE) is a significant cause of acute encephalitis syndrome (AES) in Asia, with Northeast India, particularly Assam, being a hotspot. Effective surveillance is crucial for disease control. This study aims to describe the AES surveillance system in Bongaigaon district, Assam, assess its attributes, and provide recommendations for improvement. Methods: The weekly compilation reports (Forms P, S, L) submitted by 34 sentinel surveillance sites were reviewed from January 2018 to December 2020. Nodal officers and health providers were interviewed from 38 government and one private health care facilities using a semistructured questionnaire. Result: A total of 51 AES cases and 32 JE cases were identified. The overall positivity rate was 38.6% and the case fatality rate was 18% for AES and 25% for JE. Maximum JE cases (66%) were in the age group >31 years. No JE-positive case was found below 5 years. The case incidence was 6.90 for AES and 4.33 for JE per 100,000 population. Only 1% was vaccinated. The quality of surveillance was good for most indicators, except timeliness of case detection, and representativeness of private hospitals which were found to be moderate. Conclusion: The AES surveillance system in Bongaigaon district is well established. Overall, the system is simple and acceptable and has good data quality but requires improvement for timeliness of suspected case reporting and representativeness. Inclusion of potential private hospitals in the reporting system and regular orientation of nodal officers and health care providers would improve case detection and reporting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.